Citation Impact

Citing Papers

Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study
2010
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis
2012
Recent advances in the management of AL Amyloidosis
2015
Effects of carbon monoxide exposure in patients with documented cardiac arrhythmias
1993
Systemic amyloidosis
2015 Standout
Infiltrative Cardiovascular Diseases
2010
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea
2005
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
2014 Standout
The Amyloid State of Proteins in Human Diseases
2012 Standout
The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug
2012
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100.
1990
Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis
2010
Amyloidosis: Pathogenesis and New Therapeutic Options
2011
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Paradoxical effects of exercise on the QT interval in patients with polymorphic ventricular tachycardia receiving type Ia antiarrhythmic agents.
1990
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock
2015
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
2012 Standout
Indoor air quality and health
1999 Standout
Low Expression of the Apolipoprotein B mRNA–Editing Transgene in Mice Reduces LDL Levels but Does Not Cause Liver Dysplasia or Tumors
1998 StandoutNobel
Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial
2012

Works of J. Nanas being referenced

Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone
2007
Changes in spontaneous variability of ventricular ectopic activity as a function of time in patients with chronic arrhythmias.
1988
Mechanical ventilation in conjunction with the intra-aortic balloon pump improves the outcome of patients in profound cardiogenic shock
1999
Spontaneous variability in ventricular ectopic activity during chronic antiarrhythmic therapy.
1990
Rankless by CCL
2026